Drug Database
Back to search

Finland· FI-REL-REL19044

G-Lenk

A glucosamine product containing glucosamine sulfate potassium chloride, registered in Finland by Orifarm Generics A/S. The same ATC class is registered in 14 of our 19 countries.

ATC M01AX05

Checked against Fimea (Finland) on

Informational only — not a medical device.

SOURCE REGISTER · FIFimea (Finland)normalisedG-LenkATCM01AX05REGISTER NO.FI-REL-REL19044PACKS LISTED0CHECKEDSeptember 27, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about glucosamine sulfate potassium chlorideAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Glucosamine is registered in 14 of 19 countries.

Countries holding a registration under ATC M01AX05 (glucosamine), each read from that country’s own register.

  • This record: Finland, from Fimea (Finland)
  • 8 of them publish a price we can compare per daily dose
Search glucosamine products by name

Glucosamine · ATC M01AX05

14 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Franceprice
  • Germany
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Spainprice
  • Sweden
  • United Kingdom
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of glucosamine costs, country by country.

Normalised to the WHO defined daily dose (1.5 g), so markets compare like for like.

  • 1 market with a comparable price for this class
  • Public list prices, converted to USD at the rate date shown
Open the full comparison — free accountDrug prices for market access

Glucosamine · price per daily dose (1.5 g)

USD · FX 28 Sept 2026

  • ES Spain$0.23
Median listed price per WHO defined daily dose, in each market that publishes a price. Open the full comparison

The record

At a glance

Fimea (Finland)
Active substance
Glucosamine sulfate potassium chloride
Manufacturer
Orifarm Generics A/S
Country
Finland (FI)
ATC code
M01AX05
ATC class
Glucosamine
Defined daily dose
1.5 g, O
Reimbursed
Not published by this register
Source register
Fimea (Finland)
Last checked
September 27, 2026

Packs & prices · 0

No packs listed by the register for this record.

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

2 interactions on record for glucosamine.

Graded by severity as the source publishes them — 2 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

  • Severity for every pair — free, no plan needed
  • The source, licence and sync date on every record
  • Mechanism and what to do for each pair — Growth plan
Check glucosamine against other medicinesHow interaction checks work

Glucosamine · interactions on record

2 records

  • 2 moderate

Most severe, free to view

  • DicoumarolB01AA01moderate
  • WarfarinB01AA03moderate
  • Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Mechanism and what to do, in the interaction check
Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Glucosamine in 2 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All glucosamine products

Authorised across Europe · EMA

The same active substance is authorised in 9 EEA countries. Names it is sold under:

  • Belgium · Glucosamine Pharma Nord
  • Denmark · Glucosamin Copyfarm, Glucosamin Pharma Nord
  • Estonia · Glucosamine Pharma Nord
  • Ireland · Glucosamine Pharma Nord
  • Latvia · Glucosamine Pharma Nord
  • Netherlands · Glucosamine Pharma Nord
  • Norway · Glucosamin Pharma Nord
  • Poland · Sanoflexan
  • Slovenia · Glukozamin Pharma Nord

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/f0149106-bd8a-4c51-bac7-1ecf6c79407f
GET /v1/drugs/f0149106-bd8a-4c51-bac7-1ecf6c79407f?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "ddd": "1.5",
  "form": "tabletti, kalvopäällysteinen",
  "route": null,
  "ddd_unit": "g",
  "strength": "400 mg",
  "atc_label": "glukosamiini",
  "ma_number": "18216",
  "auth_status": "Myyntilupa peruuntunut",
  "eu_ma_number": null,
  "fimea_rel_id": "REL19044",
  "authorised_at": "2004-05-04"
}
API referenceMCP serverPlans

See everything about glucosamine.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console